Endocrine Society
The Endocrine Society covers hormone health as an integrated science, public health, and policy issue, making complex endocrine research usable for clinicians, patients, journalists, and policymakers. It focuses on how hormones and endocrine-disrupting chemicals shape everyday health risks and care decisions, and it ties new evidence directly to practical steps, guidelines, and advocacy.
Hormone science as public health
The Endocrine Society positions hormone science squarely in the context of public health, not just specialist medicine. Its work emphasises that endocrine disorders and hormone-related exposures affect common conditions such as infertility, diabetes, immune deficiencies, obesity, and reproductive health. Through thematic collections and scientific statements, it highlights interactions between the endocrine system and other organ systems, including the nervous system and metabolic pathways, to show how hormonal mechanisms underlie broader disease patterns. This framing runs through its coverage of endocrine-disrupting chemicals, obesity, and chronic disease, connecting detailed biology to population-level risk and health outcomes.
The Society’s coverage is grounded in long-running engagement with endocrine science, reflecting more than a century of work at the forefront of hormone research and public health. Articles and resources for clinicians routinely extract key findings from experimental, clinical, and epidemiological studies, distilling them into accessible definitions, mechanisms of action, and clinical implications. That scientific foundation distinguishes its material from general health reporting, which tends to mention hormones or endocrine disruptors without tracing the evidence base or the specific pathways involved.
Endocrine-disrupting chemicals and environmental exposures
A defining strand of the Society’s work is sustained coverage of endocrine-disrupting chemicals (EDCs) as a global health threat.
It publishes scientific statements, topic hubs, and news articles that explain how EDCs - chemicals in plastics, pesticides, consumer products, and industrial processes - interfere with hormone action and contribute to disease. Headlines such as “Latest Science Shows Endocrine Disrupting Chemicals in Plastics Pose Health Threats Globally” underline the link between everyday exposures and rising rates of infertility, diabetes, immune deficiencies, and other serious conditions.
Coverage of studies finding EDCs in breast milk and infant urine up to age six months extends this focus to early-life exposure, stressing developmental vulnerability and long-term consequences.
The Society’s EDC content goes beyond hazard warnings to detail specific reproductive and developmental impacts. Articles on the impact of EDCs on reproductive systems describe how substances like BPA, DDT, and lead alter neuroendocrine pathways, change puberty timing, reduce sperm counts, and contribute to structural malformations and conditions such as testicular dysgenesis syndrome and endometriosis. These pieces explain mechanisms - such as binding to nuclear hormone receptors or disrupting hormone synthesis and metabolism - and tie them to observed outcomes in both humans and wildlife. This level of mechanistic and translational detail is a hallmark of the Society’s coverage and sets it apart from general environmental health reporting.
The Society also frames EDCs as a policy and prevention issue. It provides “Let’s Talk EDCs” resources that equip endocrinologists to answer patient questions and offer “seven safe and simple steps” to reduce exposure, such as avoiding canned and processed foods, limiting plastic use, and steering clear of nonstick cookware. During the pandemic, it prepared science-based EDC newsletters for European Union policymakers, showing how endocrine evidence should inform regulatory decisions. Across these formats, the Society links scientific findings to concrete behavioural advice and regulatory priorities, connecting lab and clinic to kitchen, workplace, and legislature.
Obesity, diabetes, and hormone-related chronic disease
Another recurring focus is hormone-related chronic disease, particularly obesity and diabetes in different patient populations. The Society curates thematic issues that explore obesity in relation to nutrition and physical activity, selecting articles based on scientific impact and recognition.
It is updating its clinical practice guidelines on the medical treatment of obesity with a dedicated focus group that incorporates patient perspectives, signalling that hormone-based obesity care must reflect lived experience as well as trial data.
The Society’s materials also surface hormone dimensions in widely recognised conditions such as type 2 diabetes. External coverage notes that it offers patient resources tailored to older adults with diabetes, aligning with broader concern about a looming diabetes crisis among people over 65.
By situating diabetes and obesity within endocrine pathways - rather than treating them as purely lifestyle or metabolic issues - the Society encourages clinicians and communicators to view these conditions through the lens of hormonal regulation, treatment technologies, and system-level access to care.
Guidelines, advocacy, and education for clinicians and journalists
The Endocrine Society consistently connects hormone science to health policy and professional practice. It produces clinical practice guidelines, such as those on obesity treatment, and responds to national research and policy initiatives. In its statement applauding the U.S. Preventive Services Task Force recommendations on women’s health research priorities, it calls for increased biomedical research funding to advance cures, improve treatments, and reduce healthcare costs, tying endocrine research directly to legislative and budget decisions. Its advocacy portfolio around EDCs similarly presses for regulation rooted in hormone science.
Education is a core format. Through Endocrine Society training on platforms such as AMA Ed Hub, it offers the latest endocrine research to physicians treating hormone-related diseases and disorders, including courses on accurate hormone testing and assay interpretation. It also hosts media webinars exclusively for journalists to explain complex and emerging hormone health topics, positioning itself as a primary source for reporters seeking authoritative guidance on endocrine stories.
These activities show that the Society does not just publish findings; it actively shapes how clinicians and journalists understand and communicate hormone science.
Across its output, the Endocrine Society treats endocrine health as a cross-cutting thread through environmental exposures, chronic disease, reproductive health, and policy. Its coverage stands out for combining detailed hormone mechanisms with clear, actionable messages, and for serving multiple professional audiences - clinicians, policymakers, and journalists - who rely on endocrine science to inform high-stakes decisions.
4 more health journalists.
Aislinn Antrim
Aislinn Antrim is an associate editorial director at Pharmacy Times and a journalist who connects clinical advances, regulation, and the changing role of pharmacists. She writes pharmacy-centered health coverage on chronic disease therapeutics, specialty and oncology care, workforce pressures, and advocacy. Her reporting explains FDA actions, policy shifts, drug pipelines, and the real-world effects of new evidence on patient care and pharmacy practice. She often uses interviews and expert conversations to show how pharmacists improve adherence, manage side effects, navigate access and benefits, and coordinate care with prescribers. She also covers burnout, staffing strain, and the future of pharmacy practice, with an eye on how policy and economics shape work at the dispenser.
Alex Cabrero
Alex Cabrero is an Emmy award-winning KSL TV reporter who covers where health, safety and community life meet, always focused on how decisions and events affect everyday people. He has been with KSL since 2004, bringing long experience in breaking news, public service coverage and human-centered features. His beat includes public health, emergency response, technology, local infrastructure, environment and science, framed through community well-being and resilience. He reports on issues like mental health initiatives, law enforcement staffing, environmental hazards, rescues, wildfire detection tools, land-use fights and scientific discoveries, making technical and policy details clear for a general audience. He also produces many positive, everyday-life features on families, veterans, farmers, sports and local traditions. His style is direct and conversational, often built around a central person or family whose experience carries the story across TV, digital and social platforms.
Alexandra Frost
Alexandra Frost is a freelance journalist and content marketing writer who turns expert-backed health and family guidance into clear, practical service stories. She covers consumer health, wellness, nutrition, preventive care, medical research, parenting, kids’ mental health, education, products, and lifestyle. Her reporting explains concerns such as inflammation, urinary symptoms, fiber, lung cancer screening, pain treatment, mobility, family dynamics, children’s technology use, and school readiness. She profiles clinicians and scientists, connects research to everyday decisions, and focuses on what readers should watch for, ask, or change. Frost currently writes across multiple outlets, including Good Housekeeping, Cincinnati Magazine, Wirecutter, Popular Science, Success, Healthline, Parents, Women’s Health, Reader’s Digest, Today’s Parent, the Atlantic, the Washington Post, TIME, Consumer Reports, Business Insider, and National Geographic. She also works as a freelance editor, media consultant, and content strategist.
Alexandra Pattillo
Alexandra Pattillo is a freelance journalist who pairs rigorous health and science reporting with intimate accounts of patients’ lives. She covers health, science and wellness for the BBC and other major outlets, including National Geographic, The New York Times, The Atlantic, The Guardian, Outside, CNN and Inverse. Her beat includes eating disorders, women’s health, perinatal mental health, brain health, youth sports, concussion, long-term Covid symptoms, attention, habits and behavioral science. She reports on emerging treatments such as psychedelic-assisted therapy for anorexia, testing evidence, safety and relapse risk. She explains complex research in plain language and examines how it shapes everyday choices. Her reporting uses in-depth interviews with patients, families, clinicians, researchers and coaches. Through the BBC’s Health Gap column, she also covers stigma, unequal access to care and gaps between lived experience and standard medical pathways.